Specificities of presentation of Crohn’s disease in childhood

Specificities of presentation of Crohn’s disease in childhood

ABSTRACT The incidence of inflammatory bowel disease in the pediatric population has increased in the last years. The most common form of inflammatory bowel disease is Crohn's disease and, according to its form and age of presentation, it is possible to predict the evolution of the disease.

Bibliographic Details
Main Authors:	Bruna Karoline Pinheiro França Protásio, Camila Maria Pinheiro Machado Martins Barbosa, Clarice Blaj Neufeld, Leandro Dimasi Buck, Lygia de Souza Lima Laund, Mauro Sergio Toporovski, Thais Cristina Visoni
Format:	Article
Language:	English
Published:	Instituto Israelita de Ensino e Pesquisa Albert Einstein
Series:	Einstein (São Paulo)
Subjects:	Colitis Crohn disease Prognosis Child Case reports
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082018000100500&lng=en&tlng=en

Similar Items

Crohn's and colitis diet guide : includes 150 recipes /
by: Steinhart, Allan Hillary, 1959-, et al.
Published: (2008)

A Case of Crohn’s Disease
by: Hosein Delshad, et al.
Published: (1997-09-01)

Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry
by: Lotta Elonen, et al.
Published: (2022-05-01)

Multicentric ameboma of the colon mimicking Crohn℉s disease
by: Biggs Saravanan Ramachandran, et al.
Published: (2015-04-01)

Imbalance of Controlled Death in Peripheral Blood Lymphocytes in Crohn’s Disease and Ulcerative Colitis
by: Ewa Dudzińska, et al.
Published: (2019-05-01)

Probiotics in Crohn's disease remission: a systematic review
by: Kamilla Pontes Azevedo, et al.
Published: (2022-03-01)

Platelets can reflect the severity of Crohn's disease without the effect of anemia
by: Lin Li, et al.
Published: (2020-07-01)

Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
by: Sudheer K Vuyyuru, et al.
Published: (2022-02-01)

Dermatological changes associated with non-specific inflammatory bowel diseases – Crohn’s disease and ulcerative colitis
by: Agnieszka Hołdrowicz, et al.
Published: (2020-10-01)

Surveillance for colorectal cancer and chemoprevention in ulcerative and Crohn's colitis: The need for clinical strategies to increase effectiveness
by: Affifa Farrukh, et al.
Published: (2019-10-01)

Evolução da ocorrência (1980-1999) da doença de Crohn e da retocolite ulcerativa idiopática e análise das suas características clínicas em um hospital universitário do sudeste do Brasil Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil
by: Marcellus Henrique L. P. SOUZA, et al.
Published: (2002-04-01)

¿Cuándo es demasiado pronto y cuándo demasiado tarde para la cirugía en la enfermedad de Crohn? When is it too early or too late for surgery in Crohn's disease?
by: J. I. Fernández-Blanco Hernáiz, et al.
Published: (2008-01-01)

Experience with granulocytapheresis in Crohn's disease Experiencia con la granulocitoaféresis en la enfermedad de Crohn
by: F. Cuenca, et al.
Published: (2004-07-01)

Emphysematous cystitis as a potential marker of severe Crohn's disease
by: S. M. Mahmudul Hasan, et al.
Published: (2022-04-01)

Serum levels of soluble HLA-G correlate with disease activity in pediatric patients with Crohn's disease
by: Murat Cansever, et al.
Published: (2022-01-01)

Crohn’s disease in a developing African mission hospital: a case report
by: Bamidele Johnson Alegbeleye
Published: (2019-03-01)

Mucosa-associated but not luminal <it>Escherichia coli</it> is augmented in Crohn’s disease and ulcerative colitis
by: de Souza Helton Luis, et al.
Published: (2012-12-01)

Current status of IBD and surgery of Crohn's disease in Thailand
by: Woramin Riansuwan, et al.
Published: (2021-09-01)

A pilot study of the use of the oral and faecal microbiota for the diagnosis of ulcerative colitis and Crohn's disease in a paediatric population
by: A. Monleón-Getino, et al.
Published: (2023-11-01)

Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
by: Hiroyuki Okamoto, et al.
Published: (2021-01-01)

Clinical features of nonspecific ulcerative colitis and Crohn's disease in children
by: Malakhinova N.A.
Published: (2010-09-01)

Medication use among patients with Crohn’s disease or ulcerative colitis before and after the initiation of advanced therapy
by: Theresa Hunter, et al.
Published: (2022-11-01)

Utility of four machine learning approaches for identifying ulcerative colitis and Crohn's disease
by: Jingwen Pei, et al.
Published: (2024-01-01)

Identification of ulcerative colitis and Crohn's disease based on spatial and bilinear attention network
by: QI Jing, et al.
Published: (2023-02-01)

Disease-associated reference intervals for twenty laboratory tests in patients with rheumatoid arthritis, Crohn’s disease or ulcerative colitis
by: Gustav Mikkelsen, et al.
Published: (2021-05-01)

Laparoscopic Proctocolectomy for Ulcerative Colitis and Crohn’s Disease of the Large Intestine: Short-Term and Long-Term Outcomes of 53 Cases
by: M D Kucher, et al.
Published: (2016-09-01)

Toxic megacolon complicating a first course of Crohn’s disease: about two cases
by: Rania Hefaiedh, et al.
Published: (2013-09-01)

Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease
by: Reza Yarani, et al.
Published: (2022-06-01)

Smart Model to Distinguish Crohn’s Disease from Ulcerative Colitis
by: Anna Kasperczuk, et al.
Published: (2019-04-01)

Strongyloides colitis, a rare but important mimic of Crohn’s disease, resulting in coma and multi-organ failure: a case report
by: Sabah Uddin Saqib, et al.
Published: (2022-11-01)

Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part)
by: J.K. Yamamoto-Furusho, et al.
Published: (2017-04-01)

Pathology of Inflammatory Bowel Disease
by: Shiva Raj K.C.
Published: (2015-03-01)

Ustekinumab in patients with Crohn’s disease with extraintestinal manifestations (psoriasis)
by: P. A. Makarchuk, et al.
Published: (2020-10-01)

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation
by: J.K. Yamamoto-Furusho, et al.
Published: (2017-01-01)

Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
by: Ajit Sood, et al.
Published: (2021-04-01)

Distinguishing tuberculosis and <i>Crohn′s disease</i> in developing countries: How certain can you be of the diagnosis?
by: Navaneethan Udayakumar, et al.
Published: (2009-01-01)

Crohn’s disease in childhood: modern approaches to treatment (a literature review)
by: O. M. Horbatiuk, et al.
Published: (2021-04-01)

Three‐year outcomes of childhood inflammatory bowel disease in New Zealand: A population‐based cohort study
by: Natalie G Martin, et al.
Published: (2020-08-01)

Modern Metaproteomics: A Unique Tool to Characterize the Active Microbiome in Health and Diseases, and Pave the Road towards New Biomarkers—Example of Crohn’s Disease and Ulcerative Colitis Flare-Ups
by: Céline Henry, et al.
Published: (2022-04-01)

Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
by: Hauke Christian Tews, et al.
Published: (2023-10-01)